| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.72 | 0.008 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.44 | 0.1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.33 | 0.3 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.32 | 0.1 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.28 | 0.1 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.4 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.5 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |